Giarratano, Antonino

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

Roberts, J. A., Paul, S. K., Akova, M., Bassetti, M., De Waele, J. J., Dimopoulos, G., Kaukonen, K.-M., Koulenti, D., Martin, C., Montravers, P., et al. (2014) · Clinical Infectious Diseases

Antibiotics Pharmacokinetics and EfficacyAntibiotic Use and Resistance

Cited by 1,090

Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study

Kirmeier, E., Eriksson, L. I., Lewald, H., Jonsson Fagerlund, M., Hoeft, A., Hollmann, M., Meistelman, C., Hunter, J. M., Ulm, K., Blobner, M., et al. (2019) · The Lancet Respiratory Medicine

Anesthesia and Sedative AgentsCardiac, Anesthesia and Surgical Outcomes

Cited by 372

Medical masks and Respirators for the Protection of Healthcare Workers from SARS-CoV-2 and other viruses

Ippolito, M., Vitale, F., Accurso, G., Iozzo, P., Gregoretti, C., Giarratano, A., & Cortegiani, A. (2020) · Pulmonology

Infection Control and VentilationInfection Control in Healthcare

Cited by 181

Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients

Cortegiani, A., Russotto, V., Maggiore, A., Attanasio, M., Naro, A. R., Raineri, S. M., & Giarratano, A. (2016) · Cochrane Database of Systematic Reviews

Antifungal resistance and susceptibilityNosocomial Infections in ICU

Cited by 91